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impermeable to extracellular proteins that 
can potentially act as specific, efficient, 
and tolerable drugs.[1,2] Translocation of 
macromolecular cargo is possible through 
endocytosis, and lipid raft-mediated/cave-
olar endocytosis[3,4] is exploited by viruses 
(simian virus 40 and murine polyoma-
virus,[5] and echovirus 1[6]), bacterial toxins 
(cholera and tetanus),[7] and endogenous 
proteins[8] to deliver macromolecules in 
their functional form without degrada-
tion. Targeting this clathrin-independent 
pathway is an especially attracting strategy 
because direct escape from the internal-
ized compartments is possible before 
moving to other cellular locations as 
exemplified by echovirus 1.[6] A frequent 
feature of these natural cargoes is the 
ability to bind and cluster mono-, di-, 
and trisialotetrahexosylgangliosides (GM1, 
GD1a, GT1b) during their attachment to caveolar pits, which 
induces endocytosis.[9,10] Entry through ganglioside recogni-
tion is an attractive strategy because progression of the inter-
nalized caveolae to endosomes and later to lysosomes is slow 
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1. Introduction
The mammalian cell membrane is a major obstacle in drug 
development because it represents a barrier that is mostly 
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or absent, allowing time for delivery of the contents to cell 
organelles and the cytosol[11] or transcytosis.[12,13] Selection of 
the ganglioside-mediated pathway addresses many of the chal-
lenges associated with the endocytic delivery of therapeutic 
macromolecules[14] by allowing carrier-triggered internalization 
at low concentrations and avoiding endosomal entrapment. For 
this reason, there is increasing interest in reading the glycan 
code through which gangliosides trigger lipid raft-mediated/
caveolar endocytosis.[15,16] The referenced studies identified pep-
tide sequences (13 and 16 residues) that bind to various gan-
gliosides. However, the high-affinity (low nanomolar) molecular 
recognition of gangliosides that is necessary for therapeutic 
applications is still a great challenge. Specific and high-affinity 
targeting of ganglioside GM1 is especially sought because 
GM1 is expressed in many mammalian cell types, including 
endothelial cells, and is overexpressed in cancer cells.[17,18] 
Because therapeutic protein levels in the extracellular fluid 
do not exceed the nanomolar range (clinical protocols yield 
100–500 nm),[19] high-affinity target–carrier interaction is neces-
sary to create a cell surface enrichment that facilitates sufficient 
material flux in potential clinical applications. State-of-the-art 
methods for this include the use of multimeric peptides,[20] 
supercharged protein carriers[21] and complexes of such carriers 
with cationic lipids[22] that target generic negative patches of the 
membrane, which then translocate intact functional macromol-
ecules at nanomolar concentrations.
Our goal in this work was to achieve nanomolar delivery of 
large proteins (e.g., IgG) via lipid raft-mediated/caveolar endo-
cytosis. We set out to find a short peptide tag, a non-toxic min-
imal motif that is able to specifically route its macromolecular 
cargo to an entry pathway that mimics the ganglioside-
mediated internalization of viruses and bacterial toxins through 
the major lipid raft/caveolar component GM1. By focusing on 
a structurally well-defined receptor and conducting a thorough 
biophysical characterization of the interaction, we aimed to 
open the way to structure-based design, which is rare in protein 
delivery approaches.[23,24] Here, we show that a minimal pal-
indromic pentapeptide sequence (WYKYW) specifically binds 
the carbohydrate moiety of GM1 with low nanomolar affinity. 
Direct attachment of this short endocytosis routing tag to large 
proteins facilitated lipid raft-mediated/caveolar endocytosis of 
the macromolecules at therapeutically relevant nanomolar con-
centrations and avoided endosomal entrapment and lysosomal 
degradation.
2. Results
2.1. Pentapeptide WYKYW Binds Ganglioside GM1 with High 
Affinity and Specificity
The lead molecule WYKYW (Figure 1) was first identified 
by Gabius and coworkers[25,26] as a member of the Tyr-Xxx-
Tyr-containing pentapeptide family, which was observed to 
decouple galectin-1 and proteoglycan interactions.[27] Subse-
quently, we showed that the mechanism of inhibition of the 
proteoglycan–galectin-1 interaction is a competitive binding of 
the peptide at the glycan moiety of asialofetuin.[28] Knowing 
that galectin-1 binds to ganglioside GM1,[29] we hypothesized 
that WYKYW also interacts with the extracellular glycan 
moiety of GM1. To that end, we synthesized the peptide and 
measured its affinity and specificity for different ganglio-
sides using isothermal titration calorimetry (ITC) (Figure 1; 
Figure S1a, Supporting Information) and NMR (Figure S2–S4, 
Supporting Information).
Two-stage interaction with GM1 was observed (Figure 2a) in 
which the first binding step displayed low nanomolar affinity 
with a GM1:WYKYW stoichiometry of 1:2. The second stage 
was a micromolar interaction. In the control experiment with 
pure n-dodecylphosphocholine (DPC), no interaction was 
found. Removal of the sialyl group from GM1 (asialo-GM1) was 
detrimental to binding. For ganglioside GM3, which lacks 
the terminal β-D-Gal(1→3)GalNAc, only a weak interaction 
was observed (Figure S1, Supporting Information). NMR 
spectro scopy confirmed the ITC results. Effective NMR signal 
attenuation and broadening occurred upon mixing WYKYW with 
GM1:DPC bicelles[30] (Figure S2, Supporting Information) as a 
result of the strong interaction. GM3:DPC mixture yielded partial 
line broadening in the 1H NMR spectrum, and saturation 
transfer difference (STD) signals were observed (Figure S3, 
Supporting Information), indicating weak binding involving an 
elevated exchange rate. Asialo-GM1:DPC bicelles and pure DPC 
micelles left the NMR resonances of WYKYW intact (Figure S4, 
Supporting Information), and STD could not be detected. ITC 
and NMR measurements revealed that WYKYW binds only GM1 
with low nanomolar affinity. We note that fluorescein tagging in 
the proximity of sequence WYKYW could significantly decrease 
the binding affinity to GM1 (Figure S5, Supporting Information); 
therefore, it is not a preferred setup.
2.2. The WYKYW-Tag Triggers Lipid Raft-Mediated/Caveolar 
Endocytosis of Protein Cargo at Nanomolar Concentrations
In the next step, we tested the hypothesis that the high-affinity 
WYKYW–GM1 interaction induces endocytosis when the car-
rier tag is attached to a protein. We selected FITC-labeled 
NeutrAvidin (NA) as the model cargo; we tagged it with a 
biotinyl-PEG-WYKYW conjugate (Figure 3), where PEG des-
ignates a trimeric linker obtained by coupling of 8-amino-
3,6-dioxa-octyl)succinamic acid monomer. NA binds four 
biotinylated sequences, yielding the tetravalent protein con-
struct NA(biotinyl-PEG-WYKYW)4 (Figure 3a). To assess 
the performance and the endocytosis-inducing efficiency of 
WYKYW relative to a reference cell-penetrating sequence, 
FITC-NA was tagged with biotinyl-Penetratin, yielding 
NA(biotinyl-Penetratin)4 (Figure 3b). To measure the additive 
and synergistic effects of WYKYW and Penetratin, a biotinyl-
Penetratin-GG-WYKYW chimera (NA(biotinyl-Penetratin-
GG-WYKYW)4) was also used (Figure 3c). ITC measurements 
confirmed that NA(biotinyl-PEG-WYKYW)4 and NA(biotinyl-
Penetratin-GG-WYKYW)4 bound GM1 with KDs of 14.5 ± 1.7 
and 20.8 ± 2.7 nm, respectively (Figure 2b,c). The stoichiom-
etry of the interaction was 1:1 under conditions of excess of the 
tagged protein. NA(biotinyl-Penetratin)4 displayed no affinity 
for GM1.
Live confocal laser-scanning microscopy (CLSM) experiments 
were conducted to test the entry of the WYKYW-containing 
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conjugates into cells (Figure 3d). Effective uptake of both 
NA(biotinyl-PEG-WYKYW)4 and NA(biotinyl-Penetratin-
GG-WYKYW)4 was observed over an extracellular cargo 
 concentration range of 250–1000 nm. Surprisingly, NA(biotinyl- 
Penetratin)4 did not enter the cells under these conditions, as 
can be seen from the CLSM images.
Cell internalization of the carrier-cargo constructs was quan-
tified by fluorescence-activated cell sorting (FACS) measure-
ments at cargo concentrations of 1 µm (Figure 3e) with trypan 
blue as an extracellular fluorescence quencher. The levels 
of uptake of NA(biotinyl-PEG-WYKYW)4 and NA(biotinyl-
Penetratin-GG-WYKYW)4 were similar, while the Penetratin-
tagged control NA(biotinyl-Penetratin)4 was not delivered into 
the cells. The CLSM and FACS results strongly suggest that the 
GM1 recognition sequence WYKYW was able to trigger endo-
cytosis when attached to the model protein through a linker. In 
contrast, the Penetratin-tag did not induce endocytosis of the 
cargo under these conditions (Figure 3d,e). The presence of 
Penetratin in the WYKYW-containing carrier sequence reduced 
the cell uptake efficiency relative to the PEG linker deriva-
tive (absence of additive or synergistic effects), indicating that 
WYKYW has a reliable endocytosis-inducing effect that is inde-
pendent of the linker chemistry.
Simultaneous staining of lysosomes showed no colocaliza-
tion of lysosomes with the carrier–cargo complex even after 
6 h (Figure 3d), indicating the ability of WYKYW to successfully 
target the lipid raft-mediated/caveolar endocytosis pathway. To 
gain further support for the selectivity of the cell entry mecha-
nism, we performed endocytosis inhibition experiments with 
NA(biotinyl-Penetratin-GG-WYKYW)4 in HeLa cells. The inter-
nalization of the complex could be blocked at 4 °C, proving 
that the translocation was energy-dependent (Figure 3f). After 
pretreatment of the cells with various inhibitors of endocytosis, 
we observed that methylated β-cyclodextrin (BMCD), a known 
lipid raft inhibitor, significantly decreased the entry of the com-
plex, while wortmannin and chlorpromazine had no significant 
effects. This confirmed the lipid raft-mediated/caveolar endocy-
tosis pathway (Figure 3f), consistent with the fact that GM1 is 
localized in lipid rafts and caveolae.[31] To gain additional sup-
porting evidence for the lipid raft-mediated pathway, we carried 
out a colocalization experiment with the carrier–cargo com-
plex tagged with Alexa Fluor 647 on the secondary antibody 
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-D-Glucose
-D-Galactose
N-Acetyl- -D-Galactosamine
N-Acetyl- -Neuraminidate
Sphingosine + fatty acid
Peptide WYKYW GM1 asialo-GM1 GM3+
Figure 1. Structure of the targeted ganglioside GM1 and its truncated derivatives and sequence, and structure of the lead peptide sequence WYKYW. 
Binding affinities (KD) and stoichiometries (n) for ganglioside–WYKYW interactions were measured by ITC. Parameters were obtained by nonlinear 
least squares fitting against the two-independent-binding-site and the single-binding-site models for GM1 and GM3, respectively. For asialo-GM1, the 
ITC enthalpogram did not exhibit fittable features.
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and FITC-labeled cholera toxin B subunit. Cholera toxin has 
been reported to enter cells through GM1 binding and lipid 
raft-mediated way.[7] We found srtrong correlation between 
the signals observed for cholera toxin and the carrier–cargo 
complex (Figure S6, Supporting Information), indicating that 
the carrier–cargo complex entered the cells through lipid raft-
mediated mechanism.
2.3. A Single WYKYW-Tag Is Sufficient to Trigger Endocytosis 
through Ganglioside GM1 Binding
Helenius and Pelkmans pointed out that multivalent binding/
clustering of ganglioside GM1 is necessary to trigger lipid raft-
mediated/caveolar endocytosis,[9] and the tetravalent nature of 
our model carrier–cargo complex is consistent with this obser-
vation. On the other hand, the number of copies of the carrier 
sequence required for endocytosis can be crucial, especially if 
the carrier–cargo complex is produced by recombinant syn-
thesis. To that end, we tested the uptake of the monovalent CFU-
Penetratin-GG-WYKYW conjugate, which displayed a KD of 
141 ± 45 nm toward GM1. CFU-Penetratin, which has no GM1 
binding affinity, was utilized as a control. The cellular uptake of 
these sequences by human HeLa and Jurkat cell lines was meas-
ured by FACS (Figure 4a) with trypan blue as an extracellular 
fluorescence quencher. The carriers were applied at a concen-
tration of 1 µm, which is at least one order of magnitude lower 
than the optimum concentration utilized for penetratin,[32] but 
we observed cell penetration of the stand-alone CFU-Penetratin 
without the protein cargo. The CFU-Penetratin-GG-WYKYW 
complex displayed three- and twofold increases in cell penetra-
tion efficiency in the HeLa and Jurkat cell lines, respectively, 
compared with that obtained for CFU-Penetratin without macro-
molecular cargo. The amount of intracellular cargo was twice 
as large in HeLa cells as in Jurkat cells. We hypothesized that 
the cell-dependent performance of WYKYW was related to the 
cell surface expression level of GM1. Binding experiments per-
formed with the GM1 binder cholera toxin at 4 °C (which pre-
vents endocytosis) revealed that HeLa cells expressed a higher 
level of GM1 than Jurkat cells (Figure 4c). Next, the direct GM1-
dependence of the endocytosis was tested in a competition 
experiment in which galectin-1, which binds terminal digalac-
tosides with micromolar affinity,[33] was applied as an inhibitor.
At a concentration of 10 µm, galectin-1 decreased the uptake 
of CFU-Penetratin-GG-WYKYW to the base level displayed 
by CFU-Penetratin (Figure 4b). These findings suggest that 
a single WYKYW segment is sufficient to trigger endocytosis 
through GM1 binding, leading to efficient delivery. The amount 
of internalized cargo correlated with the cell surface expression 
level of GM1 (Figure 4c). The WYKYW-tag showed a number 
of advantageous properties, and we observed no signs of cyto-
toxicity during the cell-based experiments. The possible cytotox-
icity of CFU-Penetratin-GG-WYKYW was also tested at higher 
concentrations, and it was not toxic to HeLa cells at concentra-
tions of up to 10 µm (Figure 4d), rendering it a safe candidate 
for further experiments.
Adv. Sci. 2020, 7, 1902621
Figure 2. ITC enthalpograms for a) WYKYW, b) NA(biotinyl-PEG-WYKYW)4, and c) NA(biotinyl-Penetratin-GG-WYKYW)4. Titrations were conducted 
with GM1:DPC 1:5 bicelles (solid square), and nonlinear least squares fitting was performed against the two-independent-binding-site model (solid 
lines).
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Figure 3. Schematic representation of a) NA(biotinyl-PEG-WYKYW)4, b) NA(biotinyl-Penetratin)4, and c) NA(biotinyl-Penetratin-GG-WYKYW)4. 
d) Internalization of the constructs at different concentrations by HeLa cells after 6 h as determined by live confocal laser scanning microscopy. 
FITC-labeled NA is shown in green, Hoechst 33342-stained nuclei are shown in cyan, and LysoTracker Red-stained lysosomes are shown in magenta. 
e) Internalization of the constructs at 1 µm by HeLa cells after 1 h as determined by flow cytometry. f) Influence of endocytosis inhibitors on  cellular 
uptake as determined by flow cytometry. HeLa cells were preincubated with the inhibitors wortmannin (W), chlorpromazine (CP), or β-methyl-cyclodextrin 
(BMCD) at 37 °C for 30 or 60 min and subsequently incubated with NA(biotinyl-Penetratin-GG-WYKYW)4 at 37 °C for 60 min. A control experiment 
was also performed at 4 °C. Each data point depicts the mean of three measurements; the error bars show the standard error of the mean. Statistical 
analysis was performed using one-way analysis of variance (ANOVA) with post hoc Tukey honestly significant difference test. *p < 0.1; **p < 0.01; 
***p < 0.001; ****p < 0.0001.
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2.4. The WYKYW-Tag Facilitates Intracellular Delivery of a Large 
Antibody Complex at Therapeutically Relevant Nanomolar 
Concentrations
In the next step, we investigated whether the WYKYW-tag is 
able to induce endocytosis of a large protein cargo belonging 
to the therapeutically relevant family of immunoglobulins. We 
designed a 580-kDa construct that contains NA as a connection 
hub, the WYKYW-containing carrier tag biotinyl-PEG-WYKYW 
or biotinyl-Penetratin-GG-WYKYW, a biotinylated primary 
immunoglobulin G, and a secondary antibody labeled with 
R-phycoerythrin (Figure 5a).
HeLa cells were incubated with the large carrier–cargo 
complex for 3 hours at various extracellular concentrations. 
We set out to test the possible lower limit of the affinity-driven 
endocytic material flux; therefore, we performed the experi-
ments at concentrations close to the measured KD for the 
carrier–hub complex (21 nm). To eliminate the surface-bound 
fraction, the samples were subjected to thorough washing 
with unlabeled NA(biotinyl-Penetratin-GG-WYKYW)4. 
Adv. Sci. 2020, 7, 1902621
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Figure 4. a) Uptake of fluorescently labeled sequences at 1 µm by HeLa and Jurkat cells after 1 h. b) Uptake of CFU-Penetratin and CFU-Penetratin-
GG-WYKYW at 1 µm in competition with galectin-1 at 0–10 µm. c) Cell surface expression of GM1 in HeLa and Jurkat cells measured by FITC-cholera 
toxin staining. d) Cytotoxicity of CFU-Penetratin-GG-WYKYW, biotinyl-Penetratin-GG-WYKYW, and NA(biotinyl-Penetratin-GG-WYKYW)4 at 10 µm to 
HeLa cells after 24 h as determined by bioimpedance measurements. Triton X-100 was used as a toxicity control. Each data point represents the mean 
of three measurements, and the error bars show the standard error of the mean. The unpaired Student’s t-test was used in the statistical analysis 
of the data shown in panels (a) and (c): *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. One-way analysis of variance (ANOVA) with post hoc 
Tukey honestly significant difference test was used in the statistical analysis of the data shown in panel (d): *p < 0.1; **p < 0.01; ***p < 0.001; 
****p < 0.0001.
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The carrier–IgG complex with the biotinyl-Penetratin-GG-
WYKYW conjugate was internalized over the concentration 
range of 20–160 nm (Figure 5; Figure S7 and S8, Supporting 
Information).
Unfortunately, protein precipitation was observed during 
sample preparation with biotinyl-PEG-WYKYW. This finding 
suggests that the linker region could function as a customiz-
able segment to stabilize the carrier–cargo complex in solu-
tion. Importantly, diffuse fluorescence was observed between 
the caveosomes throughout the cytoplasm when the com-
plex was applied at concentrations above 40 nm, indicating 
the ability of the system to escape the internalized compart-
ments.[34] Visual inspection suggested, however, that the 
amount of internalized cargo decreased at 20 nm. Artificial 
intelligence-aided quantitative analysis of the CLSM images 
was conducted (Figure 5b; Figure S7, Supporting Informa-
tion). The results confirmed that the complex containing 
the GM1 recognition segment WYKYW was a robust carrier 
agent that triggered endocytosis and translocation of the 580 
kDa cargo at extracellular concentrations corresponding to 
those in the lower range of therapeutic protocols (ca. 100 nm). 
The decrease in the relative amount of translocated cargo at 
approximately 20 nm was confirmed by the analysis, and that 
observation places the lower performance limit close to the KD 
value of the WYKYW–GM1 interaction. This phenomenon, 
which can be explained by the law of mass action, supports 
the idea that endocytosis of the cargo was driven by the GM1 
affinity tag. The intense intracellular fluorescence emission 
of r-phycoerythrin was a telltale sign of the functional pro-
tein. To test a possible degradation of the IgG components 
between the carrier and the r-phycoerythrin, a colocalization 
experiment was run with FITS-NA in the carrier and an Alexa 
Fluor 647-tagged secondary antibody in the cargo. We found 
very good spatial correlation between the two fluorescent sig-
nals (Figure S9, Supporting Information), which strongly sup-
ported that the molecular recognition between the primary 
and the secondary antibody was functional. As an additional 
test for the structural integrity of the primary antibody, HeLa 
cells were treated with a carrier–cargo complex containing 
only a primary anti-galectin-1 antibody attached to the carrier, 
and the internalized IgG component was visualized by using 
Atto 488-labeled galectin-1 after fixation and permeabilization 
of the cells (Figure S10, Supporting Information). The control 
cells untreated with the carrier–cargo complex did not dis-
play fluorescence, while the internalized antibody bound the 
fluorescent galectin-1 in the treated cells and fluorescence was 
observed. This finding strongly suggested that the Fv region 
the primary antibody was structurally intact.
Adv. Sci. 2020, 7, 1902621
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Figure 5. a) Schematic representation of the bottom-up designed modular carrier–hub–antibody cargo–secondary antibody–r-phycoerythrin construct. 
b) Artificial intelligence-aided quantitative analysis of the live CLSM images. HeLa cells were incubated for 6 h with various concentrations of the IgG 
complex; at least 75 representative cells were then analyzed at each concentration. The intensity value obtained for the control sample is indicated at 
zero concentration. c) Delivery of the IgG complex into HeLa cells at various concentrations after 3 h. R-phycoerythrin-conjugated secondary antibody is 
indicated in magenta; green staining defines cell membranes (WGA-FITC). Nuclei are indicated in cyan. Control cells were treated with r-phycoerythrin-
labeled secondary antibody at 160 nm for 3 h.
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3. Discussion
Mammalian cells exert strict control over macromolecular 
traffic through the cell membrane to cellular compartments. 
Lipid raft-mediated/caveolar endocytosis is the most promising 
method for delivering cargo proteins in their functional form, 
as exemplified by viruses and bacterial toxins.[15] Our concept 
was therefore to steer the macromolecular cargo toward lipid 
raft-mediated/caveolar endocytosis and to avoid the clathrin-
mediated and macropinocytosis pathways. We focused on the 
initial molecular recognition events that occur at endocytic 
membrane pits because this facilitated both the selection of the 
mechanism and the effective enrichment of the low-concentra-
tion cargo at the entry point. We found that the WYKYW-tag 
binds the glycan moiety of the caveolar receptor GM1 with high 
affinity. The lack of strong interactions with GM3 and asialo-
GM1 indicated selective behavior. We concluded that both the 
sialyl group and the terminal N-Ac-digalactoside in GM1 are 
essential structural features for the low nanomolar binding.
An important feature of the WYKYW-tag is that it can effec-
tively route the macromolecular cargo to the desired lipid raft-
mediated/caveolar endocytosis entry point, and it can induce 
the pinch-off process even when attached to a large cargo-
containing IgG proteins. Based on the specific affinity-based 
directing effect of WYKYW, we define the term “endocytosis 
routing sequence.” Although multivalent binding of caveolar 
GM1 has been reported to be necessary to trigger endocytosis, 
we found that incorporation of a single WYKYW segment into 
the chain is sufficient to initiate internalization through GM1 
binding. We note that galectin-1 acted as a competitive inhibitor 
of the GM1–WYKYW interaction but this occurred only at con-
centrations orders of magnitude higher than the endogenous in 
vivo serum galectin-1 level of 100 ng mL–1 (6.7 nm).[35] Based on 
this observation, the risk of potential in vivo inhibition of the 
endocytosis routing effect is low.
As expected for the lipid raft-mediated/caveolar pathway, the 
progression of the internalized caveolae to early endosomes 
and later to lysosomes was absent or very slow;[11,15] there-
fore, no colocalization with lysosomes was observed, sparing 
the cargo from early degradation.[36] This may have promoted 
partial escape of the cargo from the caveosomes, which could 
be observed in our experiments as diffuse intracellular fluo-
rescence. This feature opens a path to further development of 
the endocytosis routing sequence presented here. Tagging the 
protein cargo with the large fluorescent protein r-phycoerythrin 
allowed us to test the functionality of the intracellular protein. 
The selected mechanism left the protein cargo intact, as shown 
by its fluorescence even after hours of incubation. Moreover, 
the molecular recognition between the primary and secondary 
antibodies and between the primary antibody and its externally 
added antigen was functional, indicating the absence of degra-
dation of the carrier–cargo complex.
Many techniques for intracellular delivery have emerged, 
including electroporation; microinjection as a physical method; 
and the use of cationic lipid constructs, protein transduc-
tion agents, nanobodies, and cell-penetrating peptides,[22,37–39] 
including cyclic[40,41] and stapled[42] derivatives. Despite the con-
tinued development of methods for the intracellular delivery 
of macromolecules, delivery of macromolecular cargoes is 
rare; furthermore, only 4% of successfully delivered molecules 
are proteins, and very few antibodies have been  delivered.[43] 
Although some carriers have been shown to translocate 
membranes with their macromolecular cargo, micromolar 
concentrations of such carriers and their cargo are required, 
 precluding their therapeutic application,[44] especially when 
 toxicity also enters the picture.[32]
4. Conclusion
Our GM1 receptor-based modular approach is a useful alterna-
tive to the currently available carriers because the very short, 
easily applied, and nontoxic WYKYW-tag facilitates the advan-
tageous lipid raft-mediated/caveolar endocytosis in a carrier-
triggered manner, and it works at therapeutically relevant 
concentrations for cells expressing GM1. It is increasingly 
important to develop methods for cell- and tissue-specific tar-
geting of cargoes.[45] While efforts have been made to achieve 
specific targeting,[46,47] selectivity toward cancer cells is still of 
great interest. The GM1-dependent endocytosis of WYKYW-
tagged cargo offers selectivity for cell types that overexpress 
GM1, a characteristic of many tumor cells. This cell type-
dependent effect is strongly supported by the results of our 
experiments with HeLa and Jurkat cells, which display different 
amounts of GM1 on the cell surface.
5. Experimental Section
Peptide Synthesis and Purification: Peptide amides were synthesized on 
TentaGel R RAM resin using (7-azabenzotriazol-1-yl)tetramethyluronium 
hexafluorophosphate as a coupling agent (HATU). Coupling was 
performed at room temperature with three equivalents amino acid 
excess for 3 h. For the PEG-based construct, Fmoc-Ebes was coupled 
three times consecutively after the peptide sequence. The peptides were 
cleaved with TFA/water/d,l-dithiothreitol/triisopropylsilane (90:5:2.5:2.5) 
and then precipitated in ice-cold diethyl ether. The resin was washed with 
acetic acid and water and subsequently filtered and lyophilized. Peptides 
were purified by RP-HPLC on a C18 column. The HPLC eluents were 1) 
0.1% TFA in water and 2) 0.1% TFA in ACN. The purity of the peptides 
was confirmed by analytical RP-HPLC and ESI-MS measurements.
Isothermal Titration Calorimetry: ITC was performed in pH 7.2 
phosphate buffer solution using a MicroCal VP-ITC microcalorimeter. 
In individual titrations, 15 µL of solution containing GM1:DPC 1:5 was 
injected into the ligand solution in the cell (the GM1:DPC mixture was 
prepared in the same buffer as the ligand in the cell) from a computer-
controlled 300 µL microsyringe at intervals of 300 s. All measurements 
were conducted at 35 °C. The concentration of the ligand in the cell 
was 15 µm, and the concentration of GM1 in the syringe was 300 µm. 
Control experiments were performed by injecting GM1 into a cell 
containing buffer but no ligand. The experiments were repeated twice. 
We occasionally observed tailing heat response curves both in the 
actual titrations and in background measurements. To test the effects 
of the tailing on the fitted parameters, we repeated specific titrations 
with 600 s time delay between injections (Figure S1c, Supporting 
Information). Fitted affinity parameters did not exhibit marked change 
with the experimental setup, indicating that the tailing is not related 
to the binding phenomenon. After background subtraction and spline 
baseline correction, the experimental data were fitted to one-binding-
site or two-independent-site models (adjustable parameters: ΔHb1, Kd1, 
n1, and ΔHb2, Kd2, n2) using a generalized reduced gradient nonlinear 
least-squares procedure. Residual heat of mixing was observed in the 
enthalpograms due to the inert counter ions and residual solvent in the 
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peptide, protein, and lipid samples, which was corrected by including a 
constant correction term as an additional fitted parameter. Errors were 
calculated by jackknife resampling.
NMR Experiments: The 1H and STD NMR spectra were recorded on 
a Bruker AVANCE III 600 MHz spectrometer equipped with a 5 mm 
CP-TCI triple-resonance cryoprobe at 308 K. The compounds were 
dissolved in d18-HEPES buffer (20 mm, pH 6.5) containing 10% D2O. 
1H STD spectra were acquired with water suppression using excitation 
sculpting with pulsed gradients. For the 1H and STD measurements, 
the ligands and the GM1 concentrations were 20 µm. The samples were 
placed in 2.5 mm capillary NMR tubes. As a reference, STD experiments 
were also performed without the target in samples that contained the 
ligand species alone. STD NMR spectra were acquired using a series of 
40 equally spaced 50 ms Gaussian-shaped pulses for selective saturation 
of the protein, with a total saturation time of 2 s and a 50 ms spinlock to 
suppress the signal from the bicelles. The frequency of the on-resonance 
saturation was set at 1.2 ppm, and the off-resonance saturation 
frequency was set at 40.0 ppm. A total of 8k scans were collected for 
each pseudo-2D experiment.
Cell Culture: HeLa cells were cultured in advanced MEM (Gibco, 
Life Technologies) supplemented with 10% fetal bovine serum (FBS, 
PAN-Biotech). JN2B4D Jurkat cells were cultured in RPMI-1640 medium 
(Gibco) supplemented with 5% FBS. Both media contained penicillin-
streptomycin (100 U mL−1, Gibco) and 2 mm L-glutamine (Gibco). The 
cells were grown in a humidified incubator containing 5% CO2 at 37 °C.
Preparation of Carrier–Protein Complexes: To prepare peptide–NA 
complexes, biotinylated peptides were incubated with FITC-NA in cell 
culture medium at a molar ratio of 4:1. The resulting solution containing 
the complexes was added to the cells at various concentrations. To 
prepare the antibody complexes, a solution of the biotinylated peptide 
was mixed with biotinylated monoclonal mouse anti-human galectin-1 
(2c1/6) antibody[48] and labeled or unlabeled NA at a molar ratio of 
3:1:1; secondary r-phycoerythrin-conjugated goat anti-mouse IgG 
(F-[ab′]2, DakoCytomation) antibody or in some cases secondary Alexa 
Fluor 647-conjugated F(ab′)2-goat anti-mouse IgG (Invitrogen) was then 
added to the solution at a 1:1 molar ratio with the primary antibody. 
HeLa cells were incubated with various concentrations of this complex.
Flow Cytometry: The internalization of peptides and peptide–NA 
complexes was determined by flow cytometric analysis. Cells (6 × 104 
in 24-well plates) were grown at 37 °C for 24 h. After removal of the 
medium, the cells were washed with PBS and incubated with peptides 
or peptide complexes in MEM+1% FBS at 37 °C. The cells were then 
washed with PBS, harvested from the plates with 0.05% trypsin-EDTA, 
and washed with PBS. Trypan blue (Reanal) and propidium iodide 
(Fluka) were added to the cells at final concentrations of 0.1% and 
15 µm, respectively, in PBS immediately before the cells were subjected to 
flow cytometric analysis (FACSCalibur flow cytometer, BD Biosciences). 
The data were evaluated using FlowJo software (FlowJo, LLC). The 
fluorescence intensity of control cells and of the FITC-NA was subtracted 
from the fluorescence intensity of the peptides and peptide–NA 
complexes. For the measurement of ganglioside GM1 content, HeLa and 
Jurkat cells were incubated with 8 µm FITC-cholera toxin B subunit on ice 
for 30 min and then subjected to flow cytometric analysis as described 
above. For the in vitro competition assay, Jurkat cells were treated with 
1 µm peptide alone or with 1, 5, or 10 µm galectin-1. For the endocytosis 
inhibition experiments, HeLa cells were preincubated at 37 °C with 
5 mg mL−1 methyl-β-cyclodextrin (MBCD) for 60 min, 10 µm wortmannin 
for 60 min, or 10 µg mL−1 chlorpromazine for 30 min. The cells were 
then incubated with 1 µm peptide–NA complexes at 37 °C for 60 min, 
treated with trypan blue, and subjected to flow cytometric analysis as 
described above. All experiments were performed in triplicate.
Live Confocal Laser Scanning Microscopy: HeLa cells were plated 
overnight culturing in MEM+10% FBS at 1.25 × 104 cells per cm2 (or 
1.5  × 104 cells per channel) on six-chamber µ-Slides VI 0.4 (ibidi). 
The cells were washed with PBS and incubated with the studied 
complexes in MEM+1% FBS medium at different concentrations for 
different incubation times at 37 °C. The cells then were washed with 
PBS; when antibody-complexes were used, they were also washed 
with 100 mm β-lactose (Sigma-Aldrich) and the biotinylated peptide–
NA complex without the primary and secondary antibody to remove 
surface–bound complexes. The cells were stained with 100 ng mL−1 
Hoechst 33342 (Sigma-Aldrich) in MEM medium for 30 min at 37 °C. 
In some experiments, after Hoechst staining, the cells were labeled 
with LysoTracker Red (Life Technologies) at 75 nm for 30 min at 37 °C 
according to the manufacturer’s instructions. For the cholera toxin 
colocalization experiments, cells were coincubated with 5 µm FITC-
labeled CTX-B subunit (Sigma-Aldrich). For the structural test of the 
antibody complex, cells were treated with the complex for 3 h at 500 nm, 
then the cells were fixed with 1.6% paraformaldehyde for 15 min at room 
temperature, permeabilized with 0.01% saponin for 10 min, and then 
cells were stained with 350 nm Atto 488-conjugated galectin-1 for 30 min 
at room temperature.
For the IgG complex measurements, cell membranes were visualized 
after a 5 min treatment with FITC-labeled WGA lectin at 0.2 µg mL−1 
at room temperature after incubation with the complex. The cells 
were incubated in Leibovitz’s L-15 medium (Life Technologies) during 
microscopic analysis. FITC–NA complexes were treated with 0.1% 
Trypan blue to quench extracellular fluorescence. To observe the 
localization of the cargo, cell fluorescence was analyzed using a Leica 
SP5 AOBS confocal laser scanning microscope using the 405 nm UV 
diode (for Hoechst staining), the 488 nm argon laser line (for FITC and 
Atto 488 staining), the 543 nm HeNe laser line (for r-phycoerythrin and 
LysoTracker Red staining), and the 633 HeNe laser line (for Alexa Fluor 
647 staining). For emission detection, an appropriate spectral filter was 
used for each channel.
Image Analysis: To identify cells and extract their properties, we used 
Mask R-CNN, a deep learning-based image segmentation platform,[49] 
and CellProfiler software[50] for feature extraction. First, cell nuclei 
were identified based on the Hoechst signal using a very heavily 
augmented training set of The Data Science Bowl 2018 competition. 
The augmentation was performed by learning image styles and 
generating synthetic images of similar types with Pix2Pix, a generative 
adversarial network (GAN) deep network.[51] A Mask R-CNN network 
was then trained, and individual nuclei were inferred. The cytoplasm 
was approximated with a watershed region propagation algorithm 
on the FITC-WGA lectin channel. Using the detected objects (nucleus 
and cytoplasm) as masks, cellular features such as r-phycoerythrin 
intensity values, textural properties, and morphological descriptors were 
extracted. For the final statistical analysis, the integrated intensities of 
individual cells were used.
Cytotoxicity Assay: The kinetics of cell reaction to peptide treatment 
was monitored by impedance measurement at 10 kHz (RTCA 
SP instrument, ACEA Biosciences, San Diego, CA). Impedance 
measurement is noninvasive, label-free, and real-time and correlates 
linearly with the adherence, growth, number, and viability of the cells. 
For background measurements, 50 µL of cell culture medium was added 
to the wells, and HeLa cells were seeded at a density of 6 × 103 cells 
per well on noncoated 96-well plates with integrated gold electrodes 
(E-plate 96, ACEA Biosciences). At the beginning of the plateau phase 
of growth, the cells were treated with peptide solutions at 0.1, 0.5, 1, 5, 
and 10 µm, and the effects of treatment were followed for 24 h. Triton 
X-100 detergent (1 mg mL−1) was used as a reference compound to 
induce cell death. The cell index was defined as Rn-Rb at each time point 
of measurement, where Rn is the cell-electrode impedance of the well 
when it contains cells and Rb is the background impedance of the well 
containing medium alone.
Statistical Analysis: Statistical analysis included one-way analysis of 
variance (ANOVA) with post hoc Tukey honestly significant difference 
test (*p < 0.1; **p < 0.01; ***p < 0.001; ****p < 0.0001) and unpaired 
Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).
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Supporting Information is available from the Wiley Online Library or 
from the author.
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